US$ 24.11
what is the new glp 1 drug Retatrutide for weight loss: Study shows 30% body weight loss Understanding GLP-1 pills: A new
Description
This study shows that as new medications are approved we need to be careful as long term side-effects may be seen that we were not aware of. Diabetes is very common in our practices and many of our patients are put on the GPL-1s, Geffen continued

Answer : North America region will lead the global GLP-1 analogues market during the forecast period 2026 to 2035
Current evidence indicates protective effects against several malignancies (including colorectal, hepatic, and prostate cancers), whereas other studies suggest potential risks for specific cancer types, particularly thyroid cancer

Nat Rev Clin Oncol
